Tempus AI, Inc. develops artificial intelligence applications and genomic sequencing pipelines engineered for precision medicine and clinical oncology data aggregation. By constructing an extensive database of de-identified clinical records mapped directly to next-generation genomic sequencing (NGS), the firm monetizes via diagnostic sequencing fees for hospitals and high-value healthcare data analytics licensing for global pharmaceutical R&D labs.